On ECHEMI
Home > Drugs > Qingdao Shouhejinhai Pharmaceutical Ltd.
Qingdao Shouhejinhai Pharmaceutical Ltd.
  • Founded in:

    2000-06-01
  • Country:

    China China
  • Address:

    Room 707, 7th Floor, R&D Center, Qingdao Biotechnology Innovation Park, No. 377, Nanjing Road, Shibei District, Qingdao City, Shandong Province
  • Tax NO.:

    91370200718074746K
  • Registered Funds:

    19.6 million yuan
  • Website:

  • Email:

Related Drugs
Hydroxyethyl starch 130/0.4 sodium chloride injection
Name Description Content CAS NO. Registered Holders
Hydroxyethyl starch 130/0.4

This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution mode and drug concentration, as well as the dosage and infusion rate. After healthy volunteers infused 500ml of this product within 30 minutes, their volume expansion effect was 100% of the infusion volume of this product, and this 100% volume effect can be maintained stably for 4-6 hours. Using this product for isovolumetric blood replacement can maintain blood volume for at least 6 hours.

More

This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution mode and drug concentration, as well as the dosage and infusion rate. After healthy volunteers infused 500ml of this product within 30 minutes, their volume expansion effect was 100% of the infusion volume of this product, and this 100% volume effect can be maintained stably for 4-6 hours. Using this product for isovolumetric blood replacement can maintain blood volume for at least 6 hours.

0
Sodium chloride

This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution mode and drug concentration, as well as the dosage and infusion rate. After 500ml of this product was infused into healthy volunteers within 30 minutes, its volume expansion effect was 100% of the infusion volume of this product, and this 100% volume effect can be stably maintained for 4-6 hours. This product can maintain blood volume for at least 6 hours by isovolumetric blood replacement. In the subchronic toxicity test study of dogs and rats, this product was intravenously infused at 9g/kg body weight daily for 3 consecutive months, and no toxic reaction was found. During the administration period, due to the increase in liver and kidney stress response under non-physiological conditions, it can be observed that the reticuloendothelial system, liver parenchyma and other tissues of the test animals have increased uptake and metabolism of hydroxyethyl starch. The minimum toxic dose of this product for daily intravenous infusion is higher than 9g/kg body weight, which is equivalent to more than 3 times the maximum therapeutic dose of humans. Studies conducted in rats or rabbits have shown that this product has no teratogenic toxicity. When rabbits were infused with 10% hydroxyethyl starch 130/0.4 solution 50ml/kg daily, embryonic death was observed. When pregnant and lactating rats were given a single bolus of the above dose, delayed weight gain and growth of the pups were observed, and increased fluid load was observed in the mother. No studies have been conducted on the effects of this product on fertility.

More

This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution mode and drug concentration, as well as the dosage and infusion rate. After 500ml of this product was infused into healthy volunteers within 30 minutes, its volume expansion effect was 100% of the infusion volume of this product, and this 100% volume effect can be stably maintained for 4-6 hours. This product can maintain blood volume for at least 6 hours by isovolumetric blood replacement. In the subchronic toxicity test study of dogs and rats, this product was intravenously infused at 9g/kg body weight daily for 3 consecutive months, and no toxic reaction was found. During the administration period, due to the increase in liver and kidney stress response under non-physiological conditions, it can be observed that the reticuloendothelial system, liver parenchyma and other tissues of the test animals have increased uptake and metabolism of hydroxyethyl starch. The minimum toxic dose of this product for daily intravenous infusion is higher than 9g/kg body weight, which is equivalent to more than 3 times the maximum therapeutic dose of humans. Studies conducted in rats or rabbits have shown that this product has no teratogenic toxicity. When rabbits were infused with 10% hydroxyethyl starch 130/0.4 solution 50ml/kg daily, embryonic death was observed. When pregnant and lactating rats were given a single bolus of the above dose, delayed weight gain and growth of the pups were observed, and increased fluid load was observed in the mother. No studies have been conducted on the effects of this product on fertility.

7647-14-5 42
Glucose Sodium Chloride Potassium Injection
This product is a compound preparation, its components are glucose 8.0%, sodium chloride 0.18%, and potassium chloride 0.15%.
Name Description Content CAS NO. Registered Holders
GLUCOSE

Glucose is one of the main sources of energy for the human body

More

Glucose is one of the main sources of energy for the human body

8.0% 58367-01-4 14
Sodium chloride

Sodium and chloride are important electrolytes in the body and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

More

Sodium and chloride are important electrolytes in the body and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

0.18% 7647-14-5 42
Potassium chloride

Potassium is the main cation in cells. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

More

Potassium is the main cation in cells. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

0.15% 7447-40-7 38
Glucose Sodium Chloride Potassium Injection
This product is a compound preparation, its components are glucose 8.0%, sodium chloride 0.18%, and potassium chloride 0.15%.
Name Description Content CAS NO. Registered Holders
GLUCOSE

Glucose is one of the main sources of energy for the human body

More

Glucose is one of the main sources of energy for the human body

8.0% 58367-01-4 14
Sodium chloride

Sodium and chloride are important electrolytes in the body and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

More

Sodium and chloride are important electrolytes in the body and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

0.18% 7647-14-5 42
Potassium chloride

Potassium is the main cation in cells. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

More

Potassium is the main cation in cells. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

0.15% 7447-40-7 38
Oxybutynin Hydrochloride
Name Description Content CAS NO. Registered Holders
Oxybutynin hydrochloride

The specific pharmacological effect is not clear from the above information

More

The specific pharmacological effect is not clear from the above information

1508-65-2 21
Oxybutynin Hydrochloride Tablets
The main ingredient of this product is: Oxybutynin hydrochloride. Its chemical name is: alpha;-cyclohexyl-alpha;-hydroxy-phenylacetic acid-4-diethylamino-2-butynyl ester hydrochloride. Molecular formula: C22H31NO3HCl Molecular weight: 393.95
Name Description Content CAS NO. Registered Holders
Oxybutynin hydrochloride

It has strong smooth muscle spasmolytic and anticholinergic effects, and also has analgesic effects. It can selectively act on the detrusor muscle of the bladder, reduce bladder pressure, increase capacity, reduce involuntary bladder contractions, and relieve urinary urgency, urinary frequency, and urinary incontinence.

More

It has strong smooth muscle spasmolytic and anticholinergic effects, and also has analgesic effects. It can selectively act on the detrusor muscle of the bladder, reduce bladder pressure, increase capacity, reduce involuntary bladder contractions, and relieve urinary urgency, urinary frequency, and urinary incontinence.

1508-65-2 21
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.